The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020

This section has no associated Explanatory Memorandum

65.  For regulation 88 (omission of regulation 79 (failure to provide information on marketing authorisations to EMA)) substitute—U.K.

Amendment of regulation 79 (failure to provide information on marketing authorisations to EMA)

88.  In regulation 79 (failure to provide information on marketing authorisations to EMA)—

(a)in paragraph (1), for the first reference to “a marketing authorisation” substitute “ a UKMA(NI) or UKMA(UK) ”;

(b)in paragraph (2), for the first reference to “a marketing authorisation” substitute “ UKMA(NI) or UKMA(UK) ”..

Commencement Information

I1Sch. 2 para. 65 in force at 31.12.2020 immediately before IP completion day, see reg. 1